Cancer of white blood cells. Acute leukemias are characterized by the presence of blasts, which are immature white blood cells. Large quantities of blasts generally overgrow the bone marrow, leaving very little space for normal bone marrow cells. This type generally requires immediate treatment. Chronic leukemias are those characterized by a large and uncontrolled growth of more mature white blood cells.
Risk of second malignant neoplasms after childhood leukemia and lymphoma
Leukemia :: Risk of second malignant neoplasms after childhood leukemia and lymphoma
A team of 19 researchers from Australia, Canada, Iceland, Singapore, and several European countries has completed what they call the "largest population-based study of absolute and relative risk of second malignant neoplasms (SMNs)" in childhood leukemia and lymphoma survivors."Large-scale, long-term population studies are necessary to have a better understanding of the risk of second primaries among cancer patients," said study coordinator Paolo Boffetta, M.D., MPH, of the International Agency for Research on Cancer. "Most of the second primary cancers after a childhood cancer are, fortunately, rare. One therefore needs large series of patients to precisely estimate risks."
The registries used had been active for at least 25 years and covered different time periods between 1943 and 2000. Each provided individual data on leukemia, Hodgkin?s lymphoma, and Non-Hodgkin?s lymphoma, along with second cancers ? new primaries, not recurrences or metastases ? in children from infancy through age 14. The researchers? analysis found that the cumulative incidence of second cancers was 2.43 percent, 12.7 percent, and 2.5 percent within 30 years since leukemia, Hodgkin?s lymphoma and Non-Hodgkin?s lymphoma, respectively.
According to the researchers, this means that survivors of these childhood cancers are considered to be "high risk" for developing second cancers. This is especially true for Hodgkin?s lymphoma survivors: one in eight was affected within 30 years from the initial diagnosis.
"This is probably due to the better survival of Hodgkin?s lymphoma patients who received highly toxic chemotherapy, as compared to other groups of patients," Boffetta said. "In other words, chemotherapy, possibly in combination with radiotherapy, increased the survival of Hodgkin?s lymphoma patients but also their risk of developing a second cancer."
In Hodgkin?s lymphoma survivors, researchers observed an increased risk for brain, thyroid, breast, and nonmelanoma skin cancer, as well as leukemia.
The study could not assess whether risk of a second cancer varied among children who were treated in the 1940s, 50s, or 60s versus more recent decades, due to the limited follow-up time for the latter population. According to Boffetta, their risk estimates are based on patients who had past treatment regimens ? those for whom they have enough follow-up to make proper estimates. Those estimates may not reflect the risk entailed by more recent, and presumably less toxic, regimens.
"The significance of these results for adult survivors of childhood cancers is that they provide a more precise estimate of their risk of developing a second primary cancer," Boffetta said.
(Leukemia :: Risk of second malignant neoplasms after childhood leukemia and lymphoma published at SpiritIndia on Monday, April 16, 2007)
Leukemia
Search more information on Leukemia, Leukemia booksRecently posted related articles on Leukemia :
- Leukemia :: Daisies Lead Scientists Down Path to New Leukemia Drug
- Leukemia :: Drug has ability to cure type of leukemia
- Leukemia :: Daisies lead scientists down path to new leukemia drug
- Leukemia :: Novel strategy under study for aggressive leukemia
- Leukemia :: Altered expression of ultraconserved noncoding RNAs linked to human leukemias and carcinomas
- Leukemia :: Heart failure is rare among leukemia patients on imatinib
- Leukemia :: GSK's Atriance, nelarabine for leukaemias and lymphomas approved in Europe
- Leukemia :: Genetics of imatinib resistance in acute lymphoblastic leukemia
- Leukemia :: Novel MS drug shows promise in 2 lethal leukemias
- Leukemia :: Cancer Stem Cell Scientists Get $1.7M to Develop New Leukemia Drugs
Most related articles:
- Leukemia :: Risk of second malignant neoplasms after childhood leukemia and lymphoma- Leukemia :: Childhood leukemia and lymphoma survivors have elevated risk of second cancers - 23.4
- Leukemia :: Myeloid leukemia risk linked to obesity - 20.4
- Leukemia :: Rate of secondary cancers increases over years after treatment for childhood leukemia - 15.7
- Leukemia :: Clolar approved for childhood leukemia - 12.6
- Leukemia :: Predicting risk of leukemia induced by radiation therapy - 11.5
- Stroke :: Survivors of childhood leukemia, brain tumors more at risk for strokes later in life - 11.4
- Leukemia :: Arsenic triggers unique mechanism in rare leukemia - 11.2
- Prostate cancer :: Poison ivy for prostate cancer - 11.1
- Lymphoma :: Autoimmune diseases linked with Non-Hodgkin’s Lymphoma - 11
Leukemia - recent related articles/news stories:
- XMRV virus may cause prostate cancer in people- Early stem cell transplant best for acute myeloid leukemia patients
- Green tea shows promise in leukemia
- Leukemia treatment developed in Australia
- Grape seed extract may cure leukemia
»» Crohn's Disease :: Scientists find new genes for Crohn's disease
«« Hodgkin's Disease :: Genetic instability and development of second primary tumor
The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Spirit India comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com